Pyxis Oncology, Inc. (24) | Intellectual Property (6)

Browse by Subcategory

License Agreements (6 contracts)

Recent Contracts

Amended and Restated License Agreement by and between Pyxis Oncology, Inc. and Pfizer Inc., dated October 6, 2022 (Filed With SEC on November 1, 2022)
License Agreement, dated March 28, 2022 between the registrant and Biosion USA, Inc (Filed With SEC on May 13, 2022)
License Agreement by and between Pyxis Oncology, Inc. and Pfizer Inc (Filed With SEC on September 17, 2021)
Amendment No. 1 to License Agreement by and between Pyxis Oncology, Inc. and Pfizer Inc (Filed With SEC on September 17, 2021)
Exclusive License Agreement between the University of Chicago and Pyxis Oncology for Cancer Immunotherapy Technology (Filed With SEC on September 17, 2021)
First Amendment to License Agreement between Pyxis Oncology, Inc. and LegoChem Biosciences Inc (Filed With SEC on September 17, 2021)